X0206 3 2018-05-02 0 0001609550 Inspire Medical Systems, Inc. INSP 0000200406 JOHNSON & JOHNSON ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 0 0 1 0 0000924020 Johnson & Johnson Innovation - JJDC, Inc. 410 GEORGE STREET NEW BRUNSWICK NJ 08901 0 0 1 0 Series E Preferred Stock Common Stock 197863 I By Johnson & Johnson Innovation - JJDC, Inc. Series F Preferred Stock Common Stock 37388 I By Johnson & Johnson Innovation - JJDC, Inc. Shares of Series E and Series F Convertible Preferred Stock (collectively, the "Convertible Preferred Stock") have no expiration date and are convertible, at the option of the holder, into shares of Common Stock at the then-effective conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation (as amended, the "Certificate of Incorporation")). The shares of Convertible Preferred Stock will automatically convert into shares of Common Stock at the then-effective conversion rate for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Certificate of Incorporation) immediately prior to the closing of the Issuer's initial public offering. Shares of Series E Convertible Preferred Stock are convertible into shares of Common Stock at a 1-for-0.1728 conversion rate. Shares of Series F Convertible Preferred Stock are convertible into shares of Common Stock at a 1-for-0.1504 conversion rate. The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc., a wholly-owned subsidiary of the designated Reporting Person. Thomas Spellman III, Secretary of Johnson & Johnson 2018-05-02 Kevin Norman, Assistant Secretary of Johnson & Johnson Innovation - JJDC, Inc. 2018-05-02